Live Breaking News & Updates on Timothy hoey

Stay informed with the latest breaking news from Timothy hoey on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Timothy hoey and stay connected to the pulse of your community

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Buy" from Brokerages

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Buy" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Faraz-ali , Leerink-partnrs , Timothy-hoey , Investment-management , Vanguard-group-inc , Canaccord-genuity-group , Bridgeway-capital-management , Securities-exchange-commission , Capital-partners , Nasdaq , Tenaya-therapeutics-inc

Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA)

Chardan Capital reaffirmed their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $20.00 price target on the stock. TNYA has been the topic of a number of other reports. HC Wainwright restated a buy rating and set […]

United-states , Timothy-hoey , Leerink-partnrs , Securities-exchange-commission , Pricet-rowe-associates-inc , Canaccord-genuity-group , Nasdaq , Capital-partners , Tenaya-therapeutics-company-profile , Tenaya-therapeutics-inc , Vanguard-group-inc , Investment-management

Chardan Capital Reaffirms "Buy" Rating for Tenaya Therapeutics (NASDAQ:TNYA)

Chardan Capital reaffirmed their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. TNYA has been the subject of several other reports. Canaccord Genuity Group decreased their price objective on Tenaya […]

United-states , Leerink-partnrs , Timothy-hoey , Group-gp-lp-column , Casdin-capital , Securities-exchange-commission , Pricet-rowe-associates-inc , Blackrock-inc , Canaccord-genuity-group , Tenaya-therapeutics-inc , Chardan-capital , Tenaya-therapeutics

Insider Selling: Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Sells 3,300 Shares of Stock

Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) insider Timothy Hoey sold 3,300 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $7.00, for a total value of $23,100.00. Following the completion of the sale, the insider now owns 245,346 shares of the […]

United-states , Leerink-partnrs , Timothy-hoey , Capital-partners , Pricet-rowe-associates-inc , Tenaya-therapeutics-inc , Investment-management , Vanguard-group-inc , Nasdaq , Bridgeway-capital-management , Tenaya-therapeutics , Get-free-report

Insider Selling: Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Sells $23,100.00 in Stock

Insider Selling: Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Sells $23,100.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Timothy-hoey , Leerink-partnrs , Jpmorgan-chase-co , Nasdaq , Metlife-investment-management , York-mellon-corp , Blackrock-inc , Tenaya-therapeutics-inc , Tenaya-therapeutics , Get-free-report , New-york-mellon-corp

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.80

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.80
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Leerink-partnrs , Timothy-hoey , Faraz-ali , Tenaya-therapeutics-inc , Millennium-management , Balyasny-asset-management , Nasdaq , Raymond-james-associates , Tenaya-therapeutics , Get-free-report

Atticus Wealth Management LLC Invests $490,000 in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)

Atticus Wealth Management LLC purchased a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 83,438 shares of the company’s stock, valued at approximately $490,000. Atticus Wealth Management LLC owned about 0.12% of Tenaya […]

United-states , Timothy-hoey , Exchange-commission , Balyasny-asset-management , Securities-exchange-commission , Tenaya-therapeutics-inc , Nasdaq , Canaccord-genuity-group , Redwood-wealth-management-group , Morgan-stanley , Atticus-wealth-management , Barclays-plc

Insider Selling: Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Sells $30,855.18 in Stock

Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) insider Timothy Hoey sold 7,243 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $4.26, for a total value of $30,855.18. Following the completion of the transaction, the insider now owns 247,396 shares […]

United-states , California , America , Timothy-hoey , Securities-exchange-commission , Morgan-stanley , Tenaya-therapeutics-inc , Dimensional-fund-advisors , Nasdaq , America-corp , Wealth-concepts , Canaccord-genuity-group

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Timothy Hoey Sells 4,007 Shares

Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) insider Timothy Hoey sold 4,007 shares of Tenaya Therapeutics stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $3.81, for a total transaction of $15,266.67. Following the transaction, the insider now directly owns 254,639 shares in the […]

California , United-states , America , Timothy-hoey , Canaccord-genuity-group , Tenaya-therapeutics-inc , Morgan-stanley , America-corp , Nasdaq , Dimensional-fund-advisors , Securities-exchange-commission , Wealth-concepts

Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure

Tenaya’s Precision Medicine Platform Used to Identify HDAC6 Target Using Phenotypic Screening and Machine Learning Algorithms

Timothy-hoey , Tenaya-therapeutics-inc , Drug-administration , Key-research-findings , Tenaya-therapeutics , Science-translational , Chief-scientific-officer , Science-translational-medicine , Precision-medicine , Investigational-new-drug ,